Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 227 (1) , 75-81
- https://doi.org/10.1016/j.canlet.2004.11.044
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Analysis of HIC‐1 methylation and transcription in human ependymomasInternational Journal of Cancer, 2004
- The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complexNature Cell Biology, 2004
- Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor GeneCancer Research, 2004
- Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profilingCarcinogenesis: Integrative Cancer Research, 2003
- Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumorsOncogene, 2003
- Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumorsOncogene, 2002
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymomaGenes, Chromosomes and Cancer, 2001
- Molecular Genetic Analysis of Ependymal TumorsThe American Journal of Pathology, 1999
- Exon scanning for mutations of the nf2 gene in pediatric ependymomas, rhabdoid tumors and meningiomasInternational Journal of Cancer, 1995